Alliances
The alliance gives MGH preferred access to ElevateBio’s BaseCamp research, process development and manufacturing facility in Waltham, Massachusetts. The access is granted for development and production of cell and gene therapies that might be developed at MGH.
BioCity, a pioneering life science incubator and business collective, has announced a new strategic partnership with Oxford AHSN.
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company developing medicines for addictions and drug overdose, announced that it has signed an agreement with Sanofi to manufacture Opiant’s investigational agent OPNTOO4 for the treatment of Acute Cannabinoid Overdose.
Sanofi will be responsible for leading the clinical program and funding all studies needed to support the over-the-counter switch in the United States and will also be responsible for the regulatory submissions.
Today, Civica Rx announced a five-year deal with London, UK-based Hikma Pharmaceuticals to manufacture and supply Civica’s members with 14 sterile injectable drugs as a private label distributor.
ADL Bionatur Solutions (MAB: ADL), a company specialized in research and development of sustainable health and beauty products, services and industrial fermentation production, announces the expansion of its existing production agreement with Amyris, Inc.
“We are pleased to be working on this program with Gilead given their expertise and global leadership in the HIV and HBV fields,” stated James E. Brown, president and chief executive officer of DURECT.
In addition to the three preclinical assets from Novartis, Gilead has recently entered into deals to develop therapies for HIV, RA and NASH.
Bridge Biotherapeutics licensed out its BB-877 to Boehringer Ingelheim for a total deal of about $1.75 billion. This is the second large deal for fibrotic diseases Boehringer Ingelheim inked since the beginning of the month.
Bayer, Bristol-Myers Squibb and Ono Pharmaceutical Co. have teamed up to study the most common type of metastatic colorectal cancer (mCRC).
PRESS RELEASES